Abstract
Although great strides have been made in the treatment and prevention of human viral infections, antiviral drug therapy still remains problematic when compared to treatment of bacterial infections. The therapeutic toxicity/efficacy ratio of many antivirals is low, resulting in potential risks of regimen related toxicity. The number of effective antivirals is limited, and many important viral infections remain untreatable. In addition, currently used antivirals often suppress rather than cure infections, necessitating repeated, sometimes lifelong, therapy to prevent recurrences. Furthermore, the increasing use of antivirals has resulted in the selection or emergence of drug-resistant strains as has occurred following the widespread use of antibacterial (Field and Biron 1994). Finally, several medically important viruses, most notably human immunodeficiency virus (HIV), have been recalcitrant to either the development of curative chemotherapy or protective vaccines (Schnittman and Fauci 1994). Thus, novel approaches to the treatment or prevention of viral infections are constantly being sought.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alexander IE, Russell DW, Miller AD (1994) DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J Virol 68: 8282–8287
Allen ND, Cran DG, Barton SC, Hettle S, Reik R, Surani MAH (1988) Transgenes as probes for active chromosomal domains in mouse development. Nature 333: 852–855
Anderson WF (1992) Human Gene Therapy. Science 256: 808–813
Antoni BA, Rabson AB, Miller IL, Trempe JP, Chejanovsky N, Carter BJ (1991) Adeno-associated virus rep protein inhibits human immuno-deficiency virus type 1 production in human cells. J Virol 65: 396–404
Arnheiter H, Skuntz S, Noteborn M, Chang S, Meier E (1990) Transgenic mice with intracellular immunity to influenza virus. Cell 62: 51–61
Bahner I, Zhou C, Yu XJ, Hao QL, Guatelli JC, Kohn DB (1993) Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes. J Virol 67: 3199–3207
Balfour HH Jr, Benson C, Braun J, Cassens B, Erice A, Friedman-Kien A, Klein T, Polsky B, Safrin S (1994) Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. J Acquir Immune Defic Syndr 7: 254–260
Baltimore D (1988) Intracellular immunization. Nature 335: 395–396
Bantel-Schaall U, zur Hausen H (1988) Adeno-associated viruses inhibit SV40 DNA amplification and replication of herpes simplex virus in SV40-transformed hamster cells. Virology 164: 64–74
Bass BL, Weintraub H (1988) An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 55: 1089–1098
Bednarik DP, Mosca JD, Raj NBK, Pitha PM (1989) Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated alpha-2 interferon. Proc Natl Acad Sci USA 86: 4958–4962
Berns KI, Bohenzky RA (1987) Adeno-associated viruses: an update. Adv Virus Res 32: 243–306
Berns KI, Pinkerton TC, Thomas GF, Hoggan MD (1975) Detection of adeno-associated virus (AAV)-spceifie nucleotide sequences in DNA isolated from latently infected Detroit 6 cells. Virology 68: 556–560
Bevec D, Volc-Platzer B, Zimmermann K, Dobrovnik M, Hauber J, Veres G, Bohnlein E (1994) Constitutive expression of chimeric neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytes. Hum Gene Ther 5: 193–201
Bertrand EL, Rossi JJ (1994) Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1. EMBO J 13: 2904–2912
Blaese RM (1993) Development of gene therapy for immunodeficiency: adenosine deaminase deficiency. Pediatr Res 33 [Suppl]: S49-S53
Bohnlein S, Pirker FP, Hofer L, Zimmermann K, Bachmayer H, Bohnlein E, Hauber J (1991) Transdominant repressors for human T-cell leukemia virus type I rex and human immunodeficiency virus type 1 rev function. J Virol 65: 81–88
Brady HJ, Miles CG, Pennington DJ, Dzierzak EA (1994) Specific ablation of human immunodeficiency virus Tat-expressing cells by conditionally toxic retroviruses. Proc Natl Acad Sci USA 91: 365–369
Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN (1993) Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342: 1134–1137
Bruton JK, Koeller JM (1994) Recombinant interleukin-2. Pharmacotherapy 14: 635–656
Buchschacher GL, Freed EO, Panganiban AT (1992) Cells induced to express a human immunodeficiency virus type 1 envelope gene mutant inhibit the spread of wild-type virus. Hum Gene Ther 3: 391–397
Buonocore L, Rose JK (1990) Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature 345: 625–628
Buonocore L, Rose JK (1993) Blockade of human immunodeficiency virus type 1 production in CD4+ T cells by an intracellular CD4 expressed under control of the viral long terminal repeat. Proc Natl Acad Sci USA 90: 2695–2699
Carter RB, Abrams-Ogg AC, Dick JE, Kruth SA, Valli VE, Kamel-Reid S, Dube ID (1992) Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. Blood 79: 356–364
Castanotto D, Rossi JJ, Sarver N (1994) Antisense catalytic RNAs as therapeutic agents. Adv Pharm 25: 289–317
Casto BC, Armstrong JA, Atchinson RW, Hammon WMcD (1967) Studies on the relationship between adeno-associated virus type 1 (AAV-1) and adenoviruses. II. Inhibition of adenovirus plaques by AAV; its nature and specificity. Virology 33: 452–458
Cech TR, Bass BL (1986) Biological catalysis by RNA. Annu Rev Biochem 55: 599–629
Chang L-J, Stoltzfus CM (1987) Inhibition of Rous sarcoma virus replication antisense RNA. J Virol 61: 921–924
Chatterjee S, Wong KK Jr (1993) Adeno-associated viral vectors for the delivery of antisense RNA. Methods (a companion to methods. Enzymol) 5: 51–59
Chatterjee S, Johnson PR, Wong KK Jr (1992a) Dual target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector. Science 258: 1485–1488
Chatterjee S, Wong KK, Podsakoff G, Zaia J, Forman S (1992b) Adeno-associated virus vectors for high efficiency gene transfer into primary hematopoietic cells. Blood 80: 167a
Chatterjee S, Podsakoff G, Wong KK Jr (1994) Gene transfer into terminally differentiated primary human peripheral blood-derived mononuclear cells by adeno-associated virus. Blood 84: 360a
Chatterjee S, Wong KK Jr, Lu D, Permana P, Podsakoff G. Novel approaches for efficient gene transfer into hematopoietic progenitor cells: the use of adeno-associated virus vectors. Bone Marrow Transplant (in press)
Chatterjee S, Podsakoff G, Forman SJ, Wong KK Jr (1995) Adeno-associated virus-mediated gene transfer into CD34+ primary human hematopoietic progenitor cells is highly efficient and stable (submitted)
Chen SY, Khouri Y, Bagley J, Marasco WA (1994) Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody. Proc Natl Acad Sci USA 91: 5932–5936
Chuah MKL, Vandendriessche T, Chang H-K, Ensoli B, Morgan RA (1994) Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR. Hum Gene Ther 5: 1467–1475
Curiel TJ, Cook DR, Wang Y, Hahn BH, Ghosh SK, Harrison GS (1993) Long-term inhibition of clinical and laboratory human immunodeficiency virus strains in human T-cell lines containing an HIV-regulated diphtheria toxin A chain gene. Hum Gene Ther 4: 741–747
Cuypers HT, Selten G, Quint W, Zijlstra M, Maandag ER, Boelens W, van Wezenbeek P, Melief C, Berns A (1984) Murine leukemia virus-induced T-cell lymphomagensis: integration of proviruses in a distinct chromosomal region. Cell 37: 141–150
Daar ES, Li XL, Moudgil T, Ho DD (1990) High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. Proc Natl Acad Sci USA 87: 6574–6578
Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763–767
Donahue RE, Kessler SW, Bodine D, Monagh K, Dunbar C, Goodman S, Agricola B, Byrne E, Raffeid M, Meon R, Backer J, Zsebo KM, Nienhuis AW (1992) Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 176: 1125–1135
Duan L, Bagasra O, Laughlin MA, Oakes JW, Pomerantz RJ (1994) Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-rev single chain antibody. Proc Natl Acad Sci USA 91: 5075–5077
Dunbar CE, Cottier-Fox M, O’Shaughnessy JA, Dören S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, Leitman SF, Wilson WH, Cowan K, Young NS, Nienhuis AW (1995) Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85: 3048–3057
Dyson N, Howley PM, Münger K, Harlow E (1989) The human papilloma virus-16 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934–937
Eguchi Y, Itoh T, Tomizawa J (1991) Antisense RNA. Annu Rev Biochem 60: 631–652
Faraji-Shadan F, Stubbs JD, Bowman PD (1990) A putative approach for gene therapy against human immunodeficiency virus (HIV). Med Hypotheses 32: 81–84
Field AK, Biron KK (1994) The end of innocence revisited: resistance of herpesviruses to antiviral drugs. Clin Microbiol Rev 7: 1–13
Flotte TR, Afione SA, Conrad C, McGrath SA, Solow R, Oka H, Zeitlin PL, Guggino WB, Carter BJ (1993) Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 90: 10613–10617
Flotte TR, Afione SA, Zeitlin PL (1994) Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am J Respir Cell Mol Biol 11: 517–521
Flotte TR, Barraza-Ortiz X, Solow R, Afione SA, Carter BJ, Guggino WB (1995) An improved system for packaging recombinant adeno-associated virus vector capable of in vivo transduction. Gene Therapy 2: 29–37
Friedman AD, Triezenberg SJ, McKnight SL (1988) Expression of a truncated viral transactivator selectively impedes lytic infection by its cognate virus. Nature 335: 452–454
Galpin JE, Casciato DA, Richards SB (1994) A phase I clinical trial to evaluate the safety and biological activity of HIV-IT (TAF) (HIV-1 III Benv-transduced, autologous fibroblasts) in asymptomatic HIV-1 infected subjects. Hum Gene Ther 5: 997–1017
Goodman S, Xiao X, Donahue RE, Moulton A, Miller J, Walsh C, Young NS, Samulski RJ, Nienhuis AW (1994) Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 84: 1492–1500
Green M, Ishino M, Loewenstein PM (1989) Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression. Cell 58: 215–223
Green PJ, Pines O, Inouye M (1986) The role of antisense RNA in gene regulation. Annu Rev Biochem 55: 569–597
Gresser I (1986) Interferon-induced diseases. In: Notkins AL, Oldstone MBA (eds) Concepts in viral pathogenesis II. Springer, Berlin Heidelberg New York, pp 232–242
Haibert CL, Alexander IE, Wolgamot GM, Miller AD (1995) Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J Virol 69: 1473–1479
Han L, Yun JS, Wagner TE (1991) Inhibition of Moloney murine leukemia virus-induced leukemia in transgenic mice expressing antisense RNA complementary to the retroviral packaging sequences. Proc Natl Acad Sci USA 88: 4313–4317
Harrison GS, Long CJ, Curiel TJ, Maxwell F, Maxwell IH (1992) Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene. Hum Gene Ther. 3: 461–469
Hartung S, Jaenisch R, Breindl M (1986) Retrovirus insertion inactivates mouse al(l) collagen gene by blocking initiation of transcription. Nature 320: 365–367
Haseloff J, Gerlach WL (1988) Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334: 585–591
Hayward WS, Neel BG, Astrin SM (1981) Activation of a cellular oncogene by promoter insertion in ALV-induced lymphoid leukosis. Nature 290: 475–480
Helene C, Toulme J-J (1990) Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta 1049: 99–125
Hermonat PL (1989) The adeno-associated virus rep 78 gene inhibits cellular transformation induced by bovine papillomavirus. Virology 172: 253–261
Hermonat PL (1991) Inhibition of H-ras expression by the adeno-associated virus Rep78 transformation suppressor gene product. Cancer Res 51: 3373–3377
Hermonat PL (1994) Adeno-associated virus inhibits human papillomavirus type 16: a viral interaction implicated in cervical cancer. Cancer Res 54: 2278–2281
Hermonat PL, Muzyczka N (1984) Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci USA 81: 6466–6470
Herskowitz I (1987) Functional inactivation of genes by dominant negative mutations. Nature 329: 219–222
Huibregtse JM, Scheffner 1994) Mechanisms of tumor suppressor protein inactivation by the human papillomavirus E6 and E7 oncoproteins. Semin Virol 5: 357–367
James W (1991) Towards gene-inhibition therapy: a review of progress and prospects in the field of antiviral antisense nucleic acids and ribozymes. Antiviral Chem Chemother 2: 191–214
Joshi S, van Brunschot A, Asad S, van der Elst I, Read SE, Bernstein A (1991) Inhibition of human immunodeficiency virus type 1 multiplication by antisense and sense RNA expression. J Virol 65: 5524–5530
Kaniewski WK, Thomas PE (1993) Field testing of virus resistant transgenic plants. Semin Virol 4: 389–396
Kantoff PW, Gillio AP, McKachlin JR, Bordignon C, Eglitis MA, Kernan NA, Moen RC, Kohn DB, Yu S-F, Karson E, Karlsson S, Zwiebel JA, Gilboa E, Blaese RM, Nienhuis A, O’Reilly RJ, Anderson WF (1987) Expression of human adenosine deaminase in nonhuman primates after retrovirusmediated gene transfer. J Exp Med 166: 219–234
Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O’Malley KL, During MJ (1994) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet 8: 148–153
Kotin RM (1994) Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum Gene Ther 5: 793–801
Kotin RM, Siniscalco M, Samulski RJ, Zhu X, Hunter L, Laughlin CA, McLaughlin S, Muzyczka N, Rocchi M, Berns KI (1990) Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 87: 2211–2215
Kung HJ, Boerkel C, Carter TH (1991) Retroviral mutagenesis of cellular oncogenes: a review with insights into the mechanisms of insertional activation. In: Kung HJ, Vogt PK (eds) Retroviral insertional mutagenesis and oncogene activation. Springer, Berlin Heidelberg New York, pp 1–23 (Current topics in microbiology and immunology, vol 171)
LaFace D, Hermonat P, Wakeland E, Peck A (1988) Gene transfer into hematopoietic progenitor cells mediated by an adeno-associated virus vector. Virology 162: 483–486
Lebkowski JS, McNally MM, Okarma TB, Lerch LB (1988) Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Mol Cell Biol 8: 3988–3996
Lee TC, Sullenger BA, Gallardo HF, Ungers GE, Gilboa E (1992) Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells. New Biol 4: 66–74
Liem SE, Ramezani A, Li X, Joshi S (1993) The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance. Hum Gene Ther 4: 625–634
Lin X, Dashti A, Schinazi RF, Tang J (1993) Intracellular diversion of glycoprotein GP160 of human immunodeficiency virus to lysosomes as a strategy of AIDS gene therapy. FASEB J 7: 1070–1080
Lisziewicz J, Sun D, Smythe J, Lusso P, Lori F, Louie A, Markham P, Rossi J, Reitz M, Gallo RC (1993) Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Proc Natl Acad Sci USA 90: 8000–8004
Liu J, Woffendin C, Yang A, Nabel GJ (1994) Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells. Gene Ther 1: 32–27
Lu D, Chatterjee S, Brar D, Wong KK Jr (1994a) High efficiency in vitro cleavage of transcripts arising from the major transforming genes of human papillomavirus type 16 mediated by ribozymes transcribed from an adeno-associated virus-based vector. Cancer Gene Ther 1: 267–277
Lu D, Wong KK Jr, Podsakoff G, Chatterjee S (1994b) Stable and efficient adeno-associated virusmediated gene transfer into primitive human marrow-derived hematopoietic cells in long term culture. Blood 84: 360a
Lusso P, Veronese F, Ensoli B, Franchini G, Jemma C, dePocco SE, Kalyanaraman VS, Gallo RC (1990) Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science 247: 848–852
Maciejewski JP, Weichold FF, Young NS, Cara A, Zella D, Reitz MS Jr, Gallo RC (1995) Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nature Med 1: 667–673
Malim MH, Freimuth WW, Liu J, Boyle TJ, Lyerly HK, Cullen BR, Nabel GJ (1992) Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J Exp Med 176: 1197–1201
Marasco WA, Haseltine WA, Chen SY (1993) Design, intracellular expression, and activity of a human anti-human immunodeficiency virus typel gp120 single-chain antibody. Proc Natl Acad Sci USA 90: 7889–7893
Mayor HD (1993) Defective parvoviruses may be good for your health! Prog Med Virol 40: 193–205
McLaughlin SK, Collis P, Hermonat PL, Muzyczka N (1988) Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol 62: 1963–1973
Mendelson E, Grossman Z, Mileguir F, Rechavi G, Carter BJ (1992) Replication of adeno-associated virus type 2 in human lymphocytic cells and interaction with HIV-1. Virology 187: 453–463
Miller AD (1992a) Retroviral vectors. In: Muzyczka N (ed) Viral expression vectors. Springer, Berlin Heidelberg Neork, pp1–24 (Current topics in microbiology and immunology, vol 158)
Miller AD (1992b) Human gene therapy comes of age. Nature 357: 455–460
Miller DG, Adam MA, Miller AD (1990) Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10: 4239–4242
Miroshnichenko OI, Ponomareva TI, Tikchonenko TI (1989) Inhibition of adenovirus 5 replication in COS-1 cells by antisense RNAs against the viral E1a region. Gene 84: 83–89
Morgan RA, Looney DJ, Muenchau DD, Wong-Staal F, Gallo RC, Anderson WF (1990) Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS. AIDS Res Hum Retroviruses 6: 183–191
Mulligan RC (1993) The basic science of gene therapy. Science 260: 926–932
Muro-Cacho CA, Samulski RJ, Kaplan D (1992) Gene transfer in human lymphocytes using a vector based on adeno-associated virus. J Immunother 11: 231–237
Muzyczka N (1992) Use of AAV as a general transduction vector for mammalian cells. Curr Top Micorb Immunol 158: 97–129
Nabel GJ, Fox BA, Post L, Thompson CB, Woffendin C (1994) A molecular genetic intervention for AIDS-effects of a transdominant negative form of Rev. Hum Gene Ther 5: 79–92
Nakagawa Y, Kakimi K, Ling W, Kubo Y, Higo K, Masuda T, Kuribayashi K, Iwashiro M, Komatz Y, Hirama T, Adachi A, Ishimoto A (1994) Inhibition of murine AIDS (MAIDS), development by the transplantation of bone marrow cells carrying the Fv-4 resistance gene to MAIDS virus-infected mice. J Virol 68: 1438–1441
Natsoulis G, Seshaiah P, Federspiel MJ, Rein A, Hughes SH, Boeke JD (1995) Targeting of a nuclease to murine leukemia virus capsids inhibits viral multiplication. Proc Natl Acad Sci USA 92: 364–368
Oelze I, Rittner K, Sczakiel G (1994) Adeno-associated virus type 2 rep gene-mediated inhibition of basal gene expression of human immunodeficiency virus type 1 involves its negative regulatory functions. J Virol 68: 1229–1233
Ojwang JO, Hampel A, Looney DJ, Wong-Staal F, Rappaport J (1992) Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme. Proc Natl Acad Sci USA 89: 10802–10806
Ostrove JM, Duckworth DH, Berns KI (1981) Inhibition of adenovirus-transformed cell oncogenicity by adeno-associated virus. Virology 113: 521–533
Perriman R, Delves A, Gerlach WL (1992) Extended target-site specificity for a hammerhead ribozyme. Gene 113: 157–163
Podsakoff G, Wong KK Jr, Chatterjee S (1994a) Stable and efficient gene transfer into non-dividing cells by adeno-associated virus (AAV)-based vectors. J Virol 68: 5656–5666
Podsakoff G, Shaughnessy EA, Lu D, Wong KK Jr, Chatterjee S (1994b) Long term in vivo reconstitution with murine marrow cells transduced with an adeno-associated virus vector. Blood 84: 256a
Poeschla E, Wong-Staal F (1994) Antiviral and anticancer ribozymes. Curr Opin Oncol 6: 601–606
Ptashne M (1988) How eukaryotic transcriptional activators work. Nature 335: 683–689
Rhodes A, James W (1990) Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA. J Gen Virol 71: 1965–1974
Richman DD (1993) HIV drug resistance. Annu Rev Pharmacol Toxicol 33: 149–164
Rittner K, Heilbronn R, Kleinschmidt JA, Sczakiel G (1992) Adeno-associated virus type 2-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) replication: involvement of p78rep/p68 Rep and the HIV-1 long terminal repeat. J Gen Virol 73: 2977–2981
Roberts MR, Qin L, Zhang D, Smith DH, Tran AC, Dull TJ, Groopman JE, Capon DJ, Byrn RA, Finer MH (1994) Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors. Blood 84: 2878–2889
Roe TY, Reynolds TC, Yu G, Brown PO (1993) Integration of murine leukemia virus DNA depends on mitosis. EMBO J 12: 2099–2108
Rommelaere J, Cornelis JJ (1991) Antineoplastic activity of parvoviruses. J Virol Methods 33: 233–251
Salter DW, Crittenden LB (1989) Artificial insertion of a dominant gene for resistance to avian leukosis virus into the germ line of the chicken. Theor Appl Genet 77: 457–461
Sarver N, Cantin EM, Chang PS, Zaia JA, Ladne PA, Stephens DA, Rossi JJ (1990) Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247: 1222–1225
Schlehofer JR (1994) The tumor suppressive properties of adeno-associated viruses. Mutat Res 305: 303–313
Schnittman SM, Fauci AS (1994) Human immunodeficiency virus and acquired immunodeficiency syndrome: an update. Adv Intern Med 39: 305–355
Sczakiel G, Pawlita M (1991) Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA. J Virol 65: 468–472
Seif I, de Maeyer E, Riviere I, de Maeyer-Guignard J (1991) Stable antiviral expression in BALB/c 3T3 cells carrying a beta interferon sequence behind a major histocompatibility complex promoter fragment. J Virol 65: 664–671
Shepard AA, Polentino P, Duca NA (1990) Trans-dominant inhibition of herpes simplex virus transcriptional regulatory protein ICP4 by heterodimer formation. J Virol 64: 3916–3926
Shillitoe EJ, Kamath P, Chen Z (1994) Papillomaviruses as targets for cancer gene therapy. Cancer Genher 1: 193–204
Shimada T, Fujii H, Maier B, Hayashi S, Mitsuya H, Broder S, Nienhuis AW (1991) Trial of antisense RNA inhibition of HIV replication and gene expression. Antiviral Chem Chemother 2: 133–142
Smythe JA, Sun D, Thomson M, Markham PD, Reitz MS Jr, Gallo RC, Lisziewicz J (1994) A Revinducible mutant gag gene stably trasferred into T lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection. Proc Natl Acad Sci USA 91: 3657–3661
Staeheli P (1990) Interferon-induced proteins and the antiviral state. Adv Virus Res 38: 147–200
Sullenger BA, Lee TC, Smith CA, Ungers GE, Gilboa E (1990a) Expression of chimeric NA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication. Mol Cell Biol 10: 6512–6523
Sullenger BA, Gallardo HF, Ungers GE, Gilboa E (1990b) Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63: 601–608
Tratschin JD, West MH, Sandbank T, Carter BJ (1984) A human parvovirus, adeno-associated virus, as a eucaryotic vector: transient expression and encapsidation of the procaryotic gene for chloramphenicol acetyltransferase. Mol Cell Biol 4: 2072–2081
Trono D, Feinberg MB, Baltimore D (1989) HIV-1 gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 59: 113–120
Vaishnav YN, Wong-Staal F (1991) The biochemistry of AIDS. Annu Rev Biochem 60: 577–630
Van der Krol AR, Mol JNM, Stuitje AR (1988) Modulation of eukaryotic gene expression by complementary RNA or DNA sequences. Biotechniques 6: 958–976
Vieillard V, Lauret E, Rousseau V, De Maeyer E (1994) Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon beta. Proc Natl Acad Sci USA 91: 2689–2693
von Ruden T, Gilboa E (1989) Inhibition of human T-cell leukemia virus type 1 replication in primary human T cells that express antisense RNA. J Virol 63: 677–682
Wagner EGH, Simons RW (1994) Antisense RNA control in bacteria, phages, and plasmids. Annu Rev Microbiol 48: 713–742
Walsh CE, Nienhuis AW, Samulski RJ, Brown MG, Miller JL, Young NS, Liu JM (1994a) Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest 94: 1440–1448
Walsh CE, Liu IM, Wang S, Xiao X, Hashmi NJ, Zwerdling T, Agarwal R (1994b) In vivo gene transfer with a novel adeno-associated virus vector to human hematopoietic cells engrafted in SCID-hu mice. Blood 84: 256a
Warner JF, Anderson CG, Laube L, Jolly DJ, Townsend K, Chada S, St Louis D (1991) HIV-specific CTL and antibody responses in mice using retroviral vector-transduced cells. Aids Res Hum Retroviruses 7: 645–655
Watson RJ, Clemens JB (1980) A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis. Nature 285: 329–330
Weerasinghe M, Liem SE, Asad S, Read SE, Joshi S (1991) Resistance to human immunodeficiency virus type 1 (HIV-1) infection in human CD4+ lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme. J Virol 65: 5531–5534
Weintraub H, Izant JG, Harland RM (1985) Anti-sense RNA as a molecular tool for genetic analysis. Trends Genet 2: 22–25
Werge TM, Biocca S, Cattaneo A (1990) Intracellular immunization. Cloning and intracellular expression of a monoclonal antibody to the p21ras protein. FEBS Lett 274: 193–198
Werness BA, Levine A, Howley PM (1990) Association of human papilloma virus type 16 and 18 E6 proteins with p53. Science. 248: 76–79
Woffendin C, Yang ZY, Udaykumar, Xu L, Yang NS, Sheehy MJ, Nabel GJ (1994) Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells. Proc Natl Acad Sci USA 91: 11581–11585
Wong KK Jr, Chatterjee S (1992) Controlling herpes simplex virus (HSV) infections: intracellular immunization, the way of the future? Curr Top Micro Immunol 179: 159–174
Wong KK Jr, Chatterjee S (1992) In: Rouse BT (ed) Herpes Simplex virus. Springer, Berlin Heidelberg New York, pp 159–174 (Current topics in microbiology and immunology, vol 179)
Wong KK Jr, Rose JA, Chatterjee S (1991) Restriction of HSV-1 production in cell lines transduced with an antisense viral vector targeting the ICP4 gene. (Vaccine, vol 91) Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, pp 183–189
Yamada O, Yu M, Yee J-K, Kraus G, Looney D, Wong-Staal F (1994) Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1. Gene Ther 1: 38–45
Yang Q, Chen F, Trempe JP (1994) Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins. J Virol 68: 4847–4856
Yu M, Ojwang J, Yamada O, Hampel A, Rapapport J, Looney D, Wong-Staal F (1993) A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90: 6340–6344
Yu M, Poeschla E, Wong-Staal F (1994) Progress towards gene therapy for HIV infection. Gene Ther 1: 13–26
Zaia JA, Chatterjee S, Wong KK, Elkins D, Taylor NR, Rossi JJ (1992) Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy. Ann N Y Acad Sci 660: 95–105
Zhou C, Bahner IC, Larson GP, Zaia JA, Rossi JJ, Kohn DB (1994) Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-faiand rev hammerhead ribozymes. Gene 149: 33–39
Zhou SZ, Cooper S, Kang LY, Ruggieri L, Heimfeld S, Srivastava A, Broxmeyer HE (1994) Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med 179: 1867–1875
zur Hausen H, de Villiers EM (1994) Human papillomaviruses. Annu Rev Microbiol 48: 427–447
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wong, K.K., Chatterjee, S. (1996). Adeno-associated Virus Based Vectors As Antivirals. In: Berns, K.I., Giraud, C. (eds) Adeno-Associated Virus (AAV) Vectors in Gene Therapy. Current Topics in Microbiology and Immunology, vol 218. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80207-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-80207-2_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80209-6
Online ISBN: 978-3-642-80207-2
eBook Packages: Springer Book Archive